pharmaphorum

JULY 2, 2021

diff – a bacterium that causes diarrhoea and inflammation in the colon and is a major cause of illness and death worldwide – as well as other targets like inflammatory bowel disease. diff coming through clinical trials, some of which also have deep-pocketed partners. billion, but only included markets outside North America.

Bacterium 69

Bacterium Drugs Bacteria FDA Approval 69

The Pharma Data

MARCH 21, 2022

Years of toil in the laboratory have revealed how a marine bacterium makes a potent anti-cancer molecule. The anti-cancer molecule salinosporamide A, also called Marizomb, is in Phase III clinical trials to treat glioblastoma, a brain cancer. That was surprising,” she said.

Bacterium 52

Bacterium Scientist Clinical Trials Clinical Trials 52

XTalks

JULY 28, 2021

Compared to Vaxneuvance’s targeting of 15 different strains of the bacterium, Pfizer’s shot protects against 20. Both next-gen shots offer enhanced protection against bacteria that can cause pneumonia, blood infections and meningitis. This is seven more strains than its current winning vaccine Prevnar 13, which registered $5.95

FDA Approval 89

FDA Approval Vaccine Vaccination Immune Response 89

XTalks

JULY 25, 2023

Anthrax is a rare, yet severe disease caused by the bacterium B. The non-inferiority of Cyfendus to BioThrax was statistically determined in the clinical study results. Moreover, the clinical trials demonstrated that Cyfendus exhibited a favorable tolerability profile. What Is Anthrax? Additionally, at Day 64, 86.6

FDA Approval 98

FDA Approval Vaccine Vaccination Antibody 98

pharmaphorum

JUNE 16, 2022

The Medicines and Healthcare products Regulatory Agency’s (MHRA) gave a conditional approval to Idefirix – an enzyme derived from the bacterium Streptococcus pyogenes that breaks down immunoglobulin G (IgG) antibodies in the body – in 2020. The post Hansa gets NICE okay for Idefirix in kidney transplant patients appeared first on.

Antibody 52

Antibody Bacterium Medicine Clinical Trials 52

pharmaphorum

JULY 14, 2021

The shot also includes two “conserved” pneumococcal proteins – antigens that seem always to be present in the bacterium regardless of its serotype, so could potentially provide protection against an even broader range.

Immune Response 52

Immune Response Vaccination Vaccine Protein 52

The Pharma Data

JUNE 2, 2022

” In the adult phase I/II clinical trials, AFX3772 was well tolerated in participants and demonstrated good immune responses compared to the current standard of care. Phase I/II clinical trials to assess the use of the vaccine in paediatrics are planned to begin later this year. About Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

MAY 31, 2022

In the adult phase I/II clinical trials, AFX3772 was well tolerated in participants and demonstrated good immune responses compared to the current standard of care. Phase I/II clinical trials to assess the use of the vaccine in paediatrics are planned to begin later this year. Pneumococcal disease.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

XTalks

JANUARY 20, 2021

To test their hypothesis in the lab, the researchers infected mice with a stomach bacterium and fed them a protein found in egg white called ovalbumin at the same time (this protein is commonly used as a typical model food antigen in experiments). The antihistamine treatment is currently being evaluated in larger clinical trials.

Immune Response 52

Immune Response Research Allergies Protein 52

XTalks

NOVEMBER 10, 2020

Originally published on July 15, 2020: Quebec-based biotechnology company Medicago has developed a plant-derived vaccine for COVID-19 that is now undergoing early-stage clinical trials. The Phase I trials will evaluate the safety of the plant-based vaccine in a cohort of 180 healthy men and women between the ages of 18 and 55.

Vaccine 52

Vaccine Vaccination Trials Immune Response 52

XTalks

AUGUST 2, 2023

Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. At present, the company has approximately 45 new drugs in Phase II or Phase III clinical trials, or awaiting approval from regulatory authorities in the US, Europe or Japan. billion ($3.65

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

DECEMBER 24, 2020

As of November, the WHO has discouraged the use of the drug as the agency’s review of data from four different clinical trials yielded no worthy effect on mortality, need for mechanical ventilation, time to clinical improvement or any other important patient outcomes. CRISPR Therapeutics. Immunotherapies.

Life Science 111

Life Science Vaccination Vaccine Gene 111

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 1, 2025

Since then, I think it’s fair to say that most people have been nervous about the emergence of the next big infectious disease be that a virus, bacterium, fungus or parasite. (Sean Anthony Eddy/Getty Images) COVID emerged suddenly, spread rapidly and killed millions of people around the world.

Bacterium 246

Bacterium Clinical Trials Clinical Trials Clinical Research 246

AuroBlog - Aurous Healthcare Clinical Trials blog

DECEMBER 4, 2024

In 1974, German chemist Axel Zeeck and his Turkish colleague Mithat Mardin showed red pigments produced by the bacterium Streptomyces […]

Scientist 240

Scientist Bacterium Engineer Drugs 240